Modified P200TE data collection in eye disease
Official title: Modified P200TE Data Collection
Run by Optos, PLC · NCT07796230 · Data updated 2026-11-12
This study tests collecting images with a modified P200TE device from adults with retinal or other posterior eye diseases.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 22 Years and up |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Optos, PLC Industry-sponsored |
| Locations | 1 site (Louisville, Kentucky) |
| Status | Recruiting |
| Started | July 29, 2026 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | September 1, 2026 |
| Trial ID | NCT07796230 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 22 years or older with posterior segment eye disease who can tolerate ophthalmic imaging and provide informed consent at the study site.
✕Probably not a fit
Participants whose imaging is not of sufficient quality or who cannot tolerate imaging may not receive direct benefits.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects imaging data using a modified P200TE device from adults with posterior segment eye diseases. Participants must be 22 or older and able to consent and follow study procedures. The study is conducted at Bennett & Bloom Eye Centers in Louisville, KY and is sponsored by Optos, PLC. No intervention beyond imaging is involved, and the goal is to build image data for characterization of retinal conditions.
Why it matters
Potential benefit: Participants may contribute to improved understanding of imaging for retinal diseases, with potential future benefits to diagnostic methods.
How similar studies have gone: Other studies using retinal imaging devices have yielded useful image datasets, supporting the potential value of this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria Male or female participants 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed Participants who can follow the instructions by the clinical staff at the clinical site Participants who agree to participate in the study Participants with posterior segment eye disease. Example of pathologies may include but are not limited to Age-related macular degeneration, glaucoma, diabetic retinopathy, posterior uveitis, central serous chorioretinopathy, vein occlusion, epiretinal membrane and others as confirmed by the investigator. Exclusion Criteria Participants unable to tolerate ophthalmic imaging. Participants with ocular media not sufficiently clear to obtain acceptable images. Unable to obtain acceptable image quality on participant.
Where it's running
-
Bennett & Bloom Eye Centers
Louisville, Kentucky, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PathFinder 1.0 detects retinal abnormalities on macular OCT scans
This study tests PathFinder 1.0's ability to find retinal issues on macular OCT scans in adults.
-
OCT data collection from healthy and diseased eyes (A10900)
This project will collect Optical Coherence Tomography (OCT) scans from adults 22 and older who have retinal disease, glaucoma, corneal conditions, or are healthy to build a reference dataset for A10900.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.